CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
[google_news title=”” keyword=”3D bioprinting” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: 3D bioprinting
- Top 5 Videos: 3D Printing’s Diverse Dental Applicationson March 2, 2024 at 3:00 pm
First in line, 3D Systems highlights its latest dental innovations demonstrated at the AMUG 2023 event in Chicago last year. These include new materials designed for various dental applications, such ...
- Perspectives on 3D Bioprinting: Conversation with Vidmantas Šakalys from Vital3Don February 22, 2024 at 8:45 am
Charles R. Goulding and Andressa Bonafe sit down for a chat with Vidmantas Šakalys, co-founder and CEO of Vital3D Technologies.
- 3D bioprinting landmark breakthroughs signify turning point in regenerative medicineon February 22, 2024 at 4:52 am
Stratasys: GlobalData’s proprietary technology innovation intelligence tool ‘Technology Foresights’ indicates a consistent increase in the number of patents associated with 3D bioprinting over the ...
- Students create 3D-bioprinting system to replicate chemicals in plantson February 13, 2024 at 6:05 am
Meet "Team RoSynth," a group of ten students who, with their cutting-edge 3D-bioprinting system, are revolutionizing the production of plant-based pharmaceuticals without relying on actual plants.
- Bioprinting breakthrough: Tech platform creates 3D neural tissues in which neurons and glia connecton February 5, 2024 at 4:01 pm
3D bioprinting provides a more accurate method for creating human brain tissues by physically repositioning hydrogels and live cells inside a physiologically complicated cytoarchitecture.
- Printing plant-based pharmaceuticals—without plantson February 4, 2024 at 4:00 pm
Rochester undergraduates have developed a 3D-bioprinting system to replicate chemicals found in plants, including those endangered by climate change. Imagine a world without plants. Although this ...
- How is three dimensional bioprinting used for tissue and disease modelingon February 1, 2024 at 2:33 am
In recent years, the progress in 3D bioprinting has greatly enhanced tissue and disease modeling, aiding drug development and therapeutic screening. Generally, bioprinting relies on several main ...
- 3D Bioprinting in Medical Market to Reach $4.9 Billion, Globally, by 2032 at 15.5% CAGR: Allied Market Researchon January 21, 2024 at 4:00 pm
Rise in prevalence of chronic diseases, surge in usage of 3D bioprinting in biomedical applications, and advancements in 3D bioprinting drive the growth of the global 3D bioprinting in medical ...
- New Blog explores the potential of 3D bioprinting to address organ traffickingon June 14, 2023 at 2:03 am
Manchester Institute of Innovation Research's latest blog article, written by Trang Tran, an MSc Innovation Management and Entrepreneurship student, delves into the potential of 3D bioprinting in ...
- Scientists Say They've Devised a Way to 3D Print Inside the Human Bodyon March 1, 2023 at 4:01 pm
A team of engineers at the University of New South Wales in Sydney, Australia, has developed a tiny, flexible robotic arm that's designed to 3D print material directly on the surface of organs ...
via Bing News